Kyle A. Udd
Kyle A. Udd publishes mostly in Hematology, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Multiple Myeloma Research and Treatments, Monoclonal and Polyclonal Antibodies Research and Chronic Lymphocytic Leukemia Research.
- World rank
- #4,844,160 of 7,710,434 ranked researchers
- Rank in United States
- #1,266,822 of 1,627,098
- Works
- 35
- Citations
- 478
- Citations per work
- 13.7
What does Kyle A. Udd research?
Kyle A. Udd's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2262.4%
- Medicine2262.4%
- Everything else719.4%
- Life Sciences618.2%
- 1Hematology22% of their works
- 2Oncology17% of their works
- 3Radiology, Nuclear Medicine and Imaging13% of their works
- 4Genetics10% of their works
- 5Molecular Biology10% of their works
- 6Immunology8% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Monoclonal and Polyclonal Antibodies Research
- Chronic Lymphocytic Leukemia Research
- Peptidase Inhibition and Analysis
- Lymphoma Diagnosis and Treatment
- Glycosylation and Glycoproteins Research
- Protein Degradation and Inhibitors
- Immunodeficiency and Autoimmune Disorders
Which keywords describe Kyle A. Udd's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Glycosylation, Rituximab, PET Imaging, Fc Receptors, Therapeutic Antibodies and Chronic Lymphocytic Leukemia.
- PROTACs
- Genetic Mutations
- BET Bromodomains
- Classification
- Fibroblast Activation Protein
- Chronic Lymphocytic Leukemia
- Fc Receptors
- Rituximab
- International Myeloma Working Group
- Diagnosis Criteria
- Glycosylation
- PET Imaging
- Therapeutic Antibodies
- Genomic Aberrations
- Tumor Microenvironment
- Lymphoma
- Cancer
- Glycans
- Primary Immunodeficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Diagnosis Criteria171 topic
- International Myeloma Working Group171 topic
- Glycosylation122 topics
- Rituximab122 topics
- PET Imaging112 topics
- Fc Receptors91 topic
- Therapeutic Antibodies91 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- Fibroblast Activation Protein61 topic
- Tumor Microenvironment61 topic
- Classification51 topic
- Lymphoma51 topic
- BET Bromodomains31 topic
- Cancer31 topic
- Genetic Mutations31 topic
- Glycans31 topic
- PROTACs31 topic
- Primary Immunodeficiency31 topic
Where does Kyle A. Udd work?
Kyle A. Udd's main affiliation in the publication record is Institute for Myeloma & Bone Cancer Research, United States.
How many publications and citations does Kyle A. Udd have?
OpenAlex counts 35 works and 478 citations for Kyle A. Udd, an h-index of 9, ranking #4,844,160 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kyle A. Udd. Posts are plain text and can be reported.